NattoPharma Awarded Grant from Norwegian Research Council
New grant will fund substantiating MenaQ7 Vitamin K2 effect on calcium metabolismOSLO, NORWAY and METUCHEN, NJ (April 18, 2017) – The Norwegian Research Council has awarded a grant to NattoPharma to fund a 4-year project to document the effects of calcium metabolism in the body based on the presence or absence of Vitamin K2, MK7. The project will utilize NattoPharma’s MenaQ7® Vitamin K2 as MK-7 and the research part will be conducted at the Maastricht University in the Netherlands in the Department of Biochemistry under the guidance of Dr. Leon Schurgers, Senior Scientist and Associate